Home > Clinical Trials

Saved trials

Not yet recruiting
NCT05917275
Multi-Omics to Predict the Blood Pressure Response to Antihypertensives
96 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Primary Hypertension
Recruiting
NCT05122455
Effects of Edoxaban on Platelet Aggregation
70 Enrollment(s)
1 Study location(s)
Interventional (Phase II|Phase III)
SCAD
AMI
Active, not recruiting
NCT03734029
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
557 Enrollment(s)
208 Study location(s)
Interventional (Phase III)
Breast Cancer
Not yet recruiting
NCT05900206
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
370 Enrollment(s)
7 Study location(s)
Interventional (Phase II)
Breast Cancer
Active, not recruiting
NCT03505710
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer
181 Enrollment(s)
21 Study location(s)
Interventional (Phase II)
Non-Small Cell Lung Cancer
Completed
NCT04752059
Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases
15 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
Breast Cancer Stage IV
Recruiting
NCT05458401
EUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab Deruxtecan
200 Enrollment(s)
21 Study location(s)
Observational
HER2-positive Breast Cancer
Not yet recruiting
NCT05852769
A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants
18 Enrollment(s)
0 Study location(s)
Interventional (Phase I)
Healthy Volunteers